StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Cipla Limited
NSE:CIPLA.NS
Sector
Location
Market Cap
USD 14.49 B
Share Price
USD 17.67
Avg Daily Volume
1,651,707
Change (1 day)
-0.02%
Change (1 year)
-0.34%
Change (YTD)
-1.09%
Cipla Limited Total Assets for the year ending March 31, 2025: USD 4.38 B
Cipla Limited Total Assets is USD 4.38 B for the year ending March 31, 2025, a 11.54% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Cipla Limited Total Assets for the year ending March 31, 2024 was USD 3.92 B, a 9.42% change year over year.
-
Cipla Limited Total Assets for the year ending March 31, 2023 was USD 3.58 B, a 0.44% change year over year.
-
Cipla Limited Total Assets for the year ending March 31, 2022 was USD 3.57 B, a 3.91% change year over year.
-
Cipla Limited Total Assets for the year ending March 31, 2021 was USD 3.43 B, a 9.39% change year over year.
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Daiichi Sankyo Company, Limited
USD 22.33
4568.T
+0.08
0.34%
UCB SA
USD 192.33
UCB.BR
-4.34
-2.21%
Hansoh Pharmaceutical Group Company Limited
USD 3.96
3692.HK
+0.09
2.31%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Daiichi Sankyo Company, Limited
USD 22.33
4568.T
+0.08
0.34%
UCB SA
USD 192.33
UCB.BR
-4.34
-2.21%
Hansoh Pharmaceutical Group Company Limited
USD 3.96
3692.HK
+0.09
2.31%